Concussion Market Report 2026

The concussion market size has grown steadily in recent years. It will grow from $8.2 billion in 2025 to $8.58 billion in 2026 at a compound annual growth rate (CAGR) of 4.6%. The growth in the historic period can be attributed to increasing incidence of sports-related injuries, rising awareness of traumatic brain injuries, expansion of diagnostic imaging availability, growth of rehabilitation services, improved clinical assessment protocols.

The concussion market size is expected to see strong growth in the next few years. It will grow to $10.43 billion in 2030 at a compound annual growth rate (CAGR) of 5%. The growth in the forecast period can be attributed to increasing adoption of ai-assisted concussion diagnostics, rising focus on long-term brain health monitoring, expansion of remote patient monitoring solutions, growing investment in neurorehabilitation technologies, increasing demand for personalized concussion management. Major trends in the forecast period include increasing adoption of advanced neuroimaging tools, rising use of digital cognitive assessment platforms, growing integration of wearable monitoring devices, expansion of multidisciplinary rehabilitation approaches, enhanced focus on early and accurate diagnosis.

The increasing prevalence of neurological diseases is expected to drive the growth of the concussion market in the coming years. Neurological diseases include a wide range of conditions that affect the nervous system, encompassing the brain, spinal cord, and peripheral nerves. Many neurological disorders, particularly those linked to traumatic brain injuries, involve concussions as an initiating event or as a factor that worsens disease progression. Concussions can contribute to the onset, advancement, or complications of conditions such as chronic traumatic encephalopathy and post-concussion syndrome. For example, in February 2023, according to the World Health Organization, an intergovernmental organization, epilepsy, a neurological disorder, affects around 5 million people worldwide, with an incidence of 49 cases per 100,000 population in high-income countries and up to 139 cases per 100,000 in low- and middle-income countries. Therefore, the growing burden of neurological diseases is contributing to the expansion of the concussion market.

Major companies operating in the concussion market are increasingly focused on developing innovative diagnostic solutions, such as rapid point-of-care biomarker blood tests, to address rising demand driven by improved awareness of concussion-related conditions. Rapid point-of-care biomarker blood tests are performed near the patient and measure specific blood markers to support quick clinical decisions related to diagnosis, treatment, or further evaluation. For instance, in April 2024, Abbott Laboratories, a US-based medical device and diagnostics company, introduced a whole-blood rapid test for traumatic brain injury on its portable i-STAT Alinity platform. This test enables clinicians to evaluate suspected concussions at the patient’s bedside and delivers laboratory-quality results within approximately 15 minutes. Previously, traumatic brain injury testing required plasma or serum samples to be processed in centralized laboratories, but this advancement allows faster on-site assessment, potentially reducing the need for computed tomography scans and improving timely clinical decision-making in emergency and urgent care settings.

In August 2023, Oxeia Biopharmaceuticals Inc., a US-based clinical-stage biotechnology company, acquired SUN11031, a synthetic human ghrelin compound, from KineMed Inc. for an undisclosed amount. Through this acquisition, Oxeia plans to further develop SUN11031, designated as OXE103, for the treatment of concussions and other forms of acute neurotrauma. KineMed Inc. is a US-based pharmaceutical research and development company.

Major companies operating in the concussion market are Pfizer Inc., Novartis AG, Sanofi SA, Abbott Laboratories, Medtronic plc, Viatris Inc., Zydus Lifesciences Ltd., Integra LifeSciences Corporation, Nihon Kohden Corporation, Raumedic AG, Lupin Limited, NeuroPace Inc., Compumedics Limited, NeuroLogica Corporation, Neural Analytics Inc., NovaSignal Corp., Back Bay Life Science Advisors, BrainScope Company Inc., Neuro Kinetics Inc., ImPACT Applications Inc., NanoDx Inc., Neuren Pharmaceuticals Limited, Advanced Brain Monitoring Inc., ElMindA Ltd., NeurOptics Inc., InfraScan Inc., Neuro Assessment Systems Inc., NeuroTrauma Sciences LLC, SyncThink Inc., Oxeia Biopharmaceuticals Inc., Oculogica Inc., Banyan Biomarkers Inc., Emotiv Inc., BioDirection Inc.

North America was the largest region in the concussion market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the concussion market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the concussion market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are influencing the concussion market by increasing costs of imported imaging equipment, diagnostic sensors, monitoring devices, and rehabilitation technologies. Hospitals and diagnostic centers in North America and Europe are most affected due to dependence on imported high-value medical devices, while Asia-Pacific faces increased procurement costs for advanced systems. These tariffs are raising diagnostic and treatment expenses. However, they are also encouraging domestic device manufacturing, regional innovation in digital diagnostics, and adoption of software-based concussion assessment tools.

The concussion market research report is one of a series of new reports that provides concussion market statistics, including concussion industry global market size, regional shares, competitors with a concussion market share, detailed concussion market segments, market trends and opportunities, and any further data you may need to thrive in the concussion industry. This concussion market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

A concussion is a form of traumatic brain injury that occurs when a sudden impact or force to the head or body causes the brain to move rapidly within the skull. This movement can temporarily affect brain function and interfere with normal neurological activity.

The main types of concussion assessments include diagnosis and treatment. Diagnosis involves identifying the condition through evaluation of symptoms, patient medical history, and the use of diagnostic tests. Concussions are assessed using a range of devices, including imaging systems such as magnetic resonance imaging, X-rays, computed tomography scanners, monitoring devices, and others. These assessments and treatments are provided by end users such as hospitals and clinics, diagnostic centers, medical camps, and others.

The concussion market consists of revenues earned by entities by providing concussion services such as consultations, diagnostic tests, imaging studies, CT scans, MRIs, and specialized diagnostic tests. The market value includes the value of related goods sold by the service provider or included within the service offering. The concussion market also includes sales of medications such as pain relievers, anti-nausea medication, or drugs targeting sleep disturbances or mood disorders. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.